Riding High On Tamiflu ; Indian Pharma Companies Say They Are Geared to Meet the Global Demand for the Antidote to H1n1 Infection.
Summary
With demand for the antidote to H1N1 infection peaking across the world, the select Indian pharmaceutical companies are ramping up production of Tamiflu or its generic version. At least one such company, Hetero Drugs, is already in the process of supplying 1 million capsules to the Government of India and is confident of being able to deliver up to 40 million capsules to countries seeking to contain the spread of the viral.
The Hyderabad-based firm, which has a sub-licence from Roche to manufacture Tamiflu, wears a busy look these days. With the flu already claiming nearly 150 lives in Mexico and causing concern globally, Hetero and other players know this is a big chance to demonstrate their ability.See the full content of this document
Extract
Riding High On Tamiflu ; Indian Pharma Companies Say They Are Geared to Meet the Global Demand for the Antidote to H1n1 Infection.
Others such as Cipla and Ranbaxy say they are equally well placed to ramp up prod...
See the full content of this document